Stay updated with breaking news from Selecta Biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Reinet Investments SCA / Key word(s): Quarter Results Consolidated audited financial results for the year ended 31 March 2024 and proposed dividend 28-May-2024 / 07:35 CET/CEST Release
Reinet Investments SCA / Key word: Quarter Results CONSOLIDATED AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31 MARCH 2024 AND PROPOSED DIVIDEND 28-May-2024 / 07:35 CET/CEST Release of...
Reinet Investments SCA Key word Quarter Results CONSOLIDATED AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31 MARCH 2024 AND PROPOSED DIVIDEND 28May2024 0735 CETCEST Release of an ad hoc announcement
Cartesian Therapeutics' autoimmune disease treatment with re-dosable mRNA CAR-Ts. Learn about Descartes-08, a promising anti-BCMA CAR-T therapy offering deeper, longer-lasting efficacy than current standards. Analysts project substantial market capture and peak sales potential.
Takeda Pharmaceutical (NYSE:TAK – Get Free Report) and Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk. Volatility and Risk Takeda Pharmaceutical has a beta […]